Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunodeficiency as a factor in lymphomagenesis.

D T Purtilo, K Sakamoto

    Perspectives in Pediatric Pathology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunopathology of X-linked lymphoproliferative syndrome.

    Immunology today·2014
    Same author

    Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

    Blood·2000
    Same author

    A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus.

    Genomics·1997
    Same author

    Simple assay for evaluation of Epstein-Barr virus specific cytotoxic T lymphocytes.

    Journal of immunological methods·1995
    Same author

    The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient.

    Transplantation·1994
    Same author

    Variable presence of circulating cytokines in patients with sporadic or X-linked lymphoproliferative disease with fatal infectious mononucleosis.

    Pediatric hematology and oncology·1993

    The human immune system typically controls Epstein-Barr virus (EBV). Immune deficiencies, however, increase risks for EBV-related cancers and lymphoproliferative diseases.

    Area of Science:

    • Immunology
    • Virology
    • Oncology

    Background:

    • The human immune system employs diverse mechanisms to control Epstein-Barr virus (EBV) infection, usually establishing latency.
    • Immune deficiencies significantly elevate the risk of severe EBV-related complications, including lymphoproliferative disorders and malignancies.

    Purpose of the Study:

    • To investigate the immune system's response to EBV in individuals with immune deficiencies.
    • To understand the mechanisms underlying EBV-associated lymphomagenesis and leukemogenesis in vulnerable populations.

    Main Methods:

    • Analysis of immune defects in patients with X-linked lymphoproliferative syndrome (XLP).
    • Examination of EBV-induced immune dysregulation and its consequences.
    • Review of EBV-associated risks in other immune deficiency syndromes (e.g., ataxia telangiectasia, transplant recipients) and specific families.

    Related Experiment Videos

    Main Results:

    • XLP patients exhibit multiple immune defects and progressive immunoregulatory disturbances post-EBV infection, leading to severe outcomes like lymphoma.
    • Individuals with ataxia telangiectasia or those who received renal transplants face heightened risks of EBV-induced lymphoproliferative diseases.
    • Certain families with a triad of autoimmunity, immunodeficiency, and lymphoma are at increased risk for EBV-associated malignancies.

    Conclusions:

    • Immune defects, both inherited and acquired, predispose individuals to EBV-related lymphoproliferative diseases and malignancies.
    • Understanding these immune dysregulations is crucial for managing EBV infection and preventing associated cancers.